Disc Medicine stock price target raised to $153 from $132 at Cantor Fitzgerald
PositiveFinancial Markets

Disc Medicine has received a positive boost as Cantor Fitzgerald raised its stock price target from $132 to $153. This adjustment reflects growing confidence in the company's potential and could attract more investors, signaling a promising outlook for Disc Medicine's future.
— Curated by the World Pulse Now AI Editorial System